Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1052 | 1027 | 1111 | 1056 | 1133 | 1405 |
Fund Return | 5.21% | 2.67% | 11.09% | 1.85% | 2.52% | 3.46% |
Place in category | 631 | 756 | 571 | 297 | 223 | 105 |
% in Category | 59 | 73 | 51 | 34 | 34 | 21 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Euro High Yield Class C EUR Cap | 3.01B | 5.25 | 1.94 | 3.57 | ||
Euro High Yield Class C EUR Dis | 3.01B | 5.20 | 1.89 | 3.49 | ||
Euro High Yield Class I EUR Cap | 3.01B | 5.83 | 2.40 | 3.96 | ||
Euro High Yield Class N EUR Cap | 3.01B | 5.00 | 1.57 | 3.19 | ||
Euro High Yield Class R EUR Cap | 3.01B | 5.69 | 2.45 | 4.04 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU0229519474 | 3.05B | 5.36 | 0.42 | 2.29 | ||
N1 European High Yield Bond Fund AC | 3.05B | 6.27 | 1.60 | 3.49 | ||
N1 European High Yield Bond Fund Ai | 3.05B | 6.45 | 1.81 | 3.71 | ||
N1 European High Yield Bond Fund Ae | 3.05B | 5.95 | 1.17 | 3.07 | ||
N1 European High Yield Bond Fund BC | 3.05B | 6.28 | 1.57 | 3.49 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Candriam Monétaire SICAV V C | FR0013113222 | 8.26 | - | - | |
Teva Pharmaceutical Finance Netherlands II B.V 4.375% | XS2406607171 | 4.05 | - | - | |
Lorca Telecom Bondco S.A.U. 4% | XS2240463674 | 2.77 | - | - | |
Nidda Healthcare Holding GmbH 7.5% | XS2550063478 | 2.55 | - | - | |
Verisure Holding AB (publ) 3.875% | XS2204842384 | 2.26 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | BUY | BUY |
Summary | Strong Buy | Buy | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review